Pepsinogens and gastrointestinal symptoms in mountain marathon runners

Epidemiology of Injury and Illness Among Trail Runners: A Systematic Review

BACKGROUND

Trail running is characterised by large elevation gains/losses and uneven varying running surfaces. Limited information is available on injury and illness among trail runners to help guide injury and illness prevention strategies.

OBJECTIVE

The primary aim of this review was to describe the epidemiology of injury and illness among trail runners.

METHODS

Eight electronic databases were systematically searched (MEDLINE Ovid, PubMed, Scopus, SportsDiscus, CINAHL, Health Source: Nursing/Academic, Health Source: Consumer Ed., and Cochrane) from inception to November 2020. The search was conducted according to the PRISMA statement and the study was registered on PROSPERO international prospective register of systematic reviews (CRD42019135933). Full-text English and French studies that investigated injury and/or illness among trail runners participating in training/racing were included. The main outcome measurements included: trail running injury (incidence, prevalence, anatomical site, tissue type, pathology-type/specific diagnosis, severity), and illness (incidence, prevalence, symptoms, specific diagnosis, organ system, severity). The methodological quality of the included studies was assessed using an adapted Downs and Black assessment tool.

RESULTS

Sixteen studies with 8644 participants were included. Thirteen studies investigated race-related injury and/or illness and three studies included training-related injuries. The overall incidence range was 1.6-4285.0 injuries per 1000 h of running and 65.0-6676.6 illnesses per 1000 h of running. The foot was the most common anatomical site of trail running injury followed by the knee, lower leg, thigh, and ankle. Skin lacerations/abrasions were the most common injury diagnoses followed by skin blisters, muscle strains, muscle cramping, and ligament sprains. The most common trail running illnesses reported related to the gastro-intestinal tract (GIT), followed by the metabolic, and cardiovascular systems. Symptoms of nausea and vomiting related to GIT distress and dehydration were commonly reported.

CONCLUSION

Current trail running literature consists mainly of injury and illness outcomes specifically in relation to single-day race participation events. Limited evidence is available on training-related injury and illness in trail running. Our review showed that injury and illness are common among trail runners, but certain studies included in this review only focused on dermatological injuries (e.g. large number of feet blisters) and GIT symptoms. Specific areas for future research were identified that could improve the management of trail running injury and illness.

Serum concentration of gastrin, cortisol and C-reactive protein in a group of Norwegian sled dogs during training and after endurance racing: a prospective cohort study

Background

High incidences of gastritis and gastric ulceration are observed in sled dogs participating in endurance races. Exercise-induced increases in hormones like gastrin and cortisol have been suggested as possible contributing factors. An increase in C-reactive protein (CRP) has also been observed in canines during physical exercise. The aim of this study was to evaluate the effect of long distance racing on the serum concentration of gastrin, cortisol and CRP in a group of sled dogs, by comparing the results achieved early in the training season and after participating in a long distance race; “Femundløpet”. Dogs that only trained to the race, but did not compete in the race, were used as control dogs. Sixty-five sled dogs participated in the study; 46 competing dogs (25 completing and 21 non-completing the race) and 19 non-racing dogs (control dogs). The blood samples were collected in October 2012 and February 2013.

Results

The post-race serum concentration of gastrin, cortisol and CRP was significantly elevated in sled dogs participating in the race (both completing and non-completing dogs) when compared to the results from training. However, no significant differences were observed between the two sampling dates in the control dogs. Post-race results for completing and non-completing dogs were also compared. This demonstrated a significant elevation in gastrin in non-completing versus completing dogs, and a significant elevation in cortisol in completing compared to non-completing dogs.

Conclusions

Participation in a long distance race was associated with a significant increase in serum gastrin, cortisol and CRP in sled dogs.

Electronic supplementary material

The online version of this article (doi:10.1186/s13028-016-0204-9) contains supplementary material, which is available to authorized users.

Gastritis and Gastric Ulcers in Working Dogs

Gastritis and gastric ulcers are an important cause of morbidity and mortality in canine athletes. Although the majority of scientific work on this condition has been performed in ultraendurance racing sled dogs, this condition has been identified in other canine athletes, including sled dogs competing in shorter events and dogs performing off-leash explosive detection duties. The cause of the syndrome is unknown, but current hypotheses propose a link between exercise-induced hyperthermia and loss of gastric mucosal barrier function as an early event in the pathogenesis. Treatment is focused on prevention of clinical disease using acid secretion inhibitors, such as omeprazole, which has excellent efficacy in controlled clinical studies.

Effect of exercise on gastric health in field retrievers

Exercise-induced gastrointestinal disease (EIGD) has been reported in all domestic athletes. In dogs and humans, EIGD is most commonly associated with ultra-endurance racing sled dogs and marathon/triathlon competitors, respectively, suggesting that the syndrome is specifically a function of prolonged exercise. However, EIGD is also common in horses that exercise for brief periods, and more recently, EIGD has been identified in Labrador retrievers that perform off-leash explosive detection patrols. In this study, we tested the hypothesis that EIGD could be induced in retrievers performing competition-style retrieves. Gastric endoscopy and histopathological examination of gastric biopsies were performed on 10 healthy retrievers before and 24 h after a series of multi-set retrieves totalling over 5 km. Although the exercise challenge resulted in a small but statistically significant increase in gastric endoscopy severity score, it did not result in a higher prevalence of clinically-significant gastric disease or changes in gastric histopathology. We conclude that competitive retrieving is unlikely to induce clinically-significant gastric disease in healthy dogs.

Increased gastrin gene expression provides a physiological advantage to mice under hypoxic conditions

Hypoxia, or a low concentration of O2, is encountered in humans undertaking activities such as mountain climbing and scuba diving and is important pathophysiologically as a limiting factor in tumor growth. Although data on the interplay between hypoxia and gastrins are limited, gastrin expression is upregulated by hypoxia in gastrointestinal cancer cell lines, and gastrins counterbalance hypoxia by stimulating angiogenesis in vitro and in vivo. The aim of this study was to determine if higher concentrations of the gastrin precursor progastrin are protective against hypoxia in vivo. hGAS mice, which overexpress progastrin in the liver, and mice of the corresponding wild-type FVB/N strain were exposed to normoxia or hypoxia. Iron status was assessed by measurement of serum iron parameters, real-time PCR for mRNAs encoding critical iron regulatory proteins, and Perls' stain and atomic absorption spectrometry for tissue iron concentrations. FVB/N mice lost weight at a faster rate and had higher sickness scores than hGAS mice exposed to hypoxia. Serum iron levels were lower in hGAS than FVB/N mice and decreased further when the animals were exposed to hypoxia. The concentration of iron in the liver was strikingly lower in hGAS than FVB/N mice. We conclude that increased circulating concentrations of progastrin provide a physiological advantage against systemic hypoxia in mice, possibly by increasing the availability of iron stores. This is the first report of an association between progastrin overexpression, hypoxia, and iron homeostasis.

Efeitos do exercício físico sobre o trato gastrintestinal

O impacto do exercício sobre o trato gastrintestinal (TGI), apesar de pouco investigado, é uma área de grande interesse. O exercício aeróbio intenso e de longa duração pode provocar sintomas gastrintestinais. Estes podem ser divididos em sintomas superiores (vômitos, náuseas e pirose retroesternal - azia) e inferiores (diarréia, cólica abdominal, perda de apetite, sangramento, aceleração dos movimentos intestinais e vontade de defecar). A etiologia desses sintomas durante o exercício é multifatorial e inclui a redução do fluxo sanguíneo intestinal, a liberação de hormônios gastrintestinais, o estresse mecânico sobre o TGI, a desidratação, os fatores psicológicos, a idade, o sexo, a dieta e o nível de treinamento do indivíduo. Por outro lado, o exercício de baixa intensidade tem efeito protetor sobre o TGI, principalmente com relação à predisposição a certas doenças como o câncer de cólon, a diverticulite, a colelitíase e a constipação. Diversos mecanismos são postulados para explicar os efeitos do exercício sobre o TGI, contribuindo para o desenvolvimento de estratégias terapêuticas no tratamento de indivíduos com sintomas e doenças gastrintestinais.

Behaviour of haematological parameters in athletes performing marathons and ultramarathons in altitude ('skyrunners')

We observed athletes performing marathons and ultramarathons in altitude over several years to study the behaviour of haematological parameters in order to screen eventual paraphysiological or pathological conditions (sports anaemia). We collected samples from 124 athletes participating in seven races; 23 athletes were recruited in different races: 16 for four times, four for three times, and three for two times. The pre- and post-race values of erythrocytes, haemoglobin and packed cell volume did not show statistically significant differences in the studied athletes. The erythrocytes' indices (MCV, MCH, MCHC) and red cell distribution width (RDW) also were not significantly modified by the strenuous effort. The leukocytes were significantly increased because of immunological involvement during the endurance performance. Platelets and relative indices were not significantly modified. The stability of packed cell volume and haemoglobin in athletes performing training and races in altitude is strong evidence for the use of these parameters as an index of general health status and for illustrating possible abnormal increase because of exogenous stimulation of bone marrow. The preanalytical and analytical accuracy is crucial to assure clinical validity of the collected data: we strictly observed international recommendations in this field.

Pepsinogens: physiology, pharmacology pathophysiology and exercise

Human gastric mucosa contains aspartic proteinases that can be separated electrophoretically on the basis of their physical properties into two major groups: Pepsinogen I (PGA, PGI); and Pepsinogen II (PGC, PGII). Pepsinogens consist of a single polypeptide chain with molecular weight of approximately 42,000 Da. Pepsinogens are mainly synthesized and secreted by the gastric chief cells of the human stomach before being converted into the proteolytic enzyme pepsin, which is crucial for the digestive processes in the stomach. Pepsinogen synthesis and secretion are regulated by positive and negative feed-back mechanisms. In the resting state pepsinogens are stored in granules, which inhibit further synthesis. After appropriate physiological or external chemical stimuli, pepsinogens are secreted in the stomach lumen where hydrochloric acid, secreted by the parietal cells, converts them into the corresponding active enzyme pepsins. The stimulus-secreting coupling mechanisms of pepsinogens appear to include at least two major pathways: one involving cAMP as a mediator, the other involving modification of intracellular Ca(2+)concentration. Physiological or external chemical stimuli acting through the intracellular metabolic adenyl cyclase are more effective in inducing ' de novo ' pepsinogen synthesis than those acting through intracellular Ca(2+). The activation of protein kinase C (PK-C) would appear to be involved in regulatory processes. The measurement of pepsinogens A and C in the serum is considered to be one of the non-invasive biochemical markers for monitoring peptic secretion and obtaining information on the gastric mucosa status of healthy subjects. Recently, pepsinogen measurements have been used as an effective biochemical method for evaluating and monitoring patients with gastrointestinal diseases and for checking the effects of drug treatment. The level of PGA in the serum is always high in normal gastritis, while in atrophic gastritis it is always low. In both cases the PGC level in the serum is high. In most gastrointestinal pathologies the ratio between the PGA/PGC decreases. Various reports concerning hormone and/or enzyme modification as well as gastrointestinal distress in the case of long distance exercise have been reported. It has been suggested that the origin of the gastrointestinal distress experienced by long distance runners is a transient ischaemia of the gastric mucosa; it is also suggested that a hypobaric-hypoxic environment could contribute to induce gastric mucosa necrosis. Interrelation between gastrointestinal distress, hypobaric-hypoxic environment and modifications of PGA and PGC, gastrin and cortisol was evaluated in 13 athletes after a marathon performed at 4300 m. Gastrointestinal symptoms occurred in approximately 40% of the athletes. After the race the athletes showed a significant increase of gastrin and cortisol, while the ratio between PGA/PGC decreased. No relationship was observed between gastrointestinal symptoms and hormonal changes after the race. A control group of five subjects, who had been exposed to the same environmental conditions, showed no gastrointestinal or hormonal alteration. Conversely, control subjects presented a significant decrease of cortisol related to the circadian rhythm. The same incidence of gastrointestinal symptoms at high altitude and at sea level and the absence of pathological alteration of PGA and PGC in the serum of the athletes indicates that running a marathon and living for 6 days at 4300 m does not induce gastric mucosa necrosis. Cortisol and gastrin alteration observed in the athletes at this altitude would seem to be related to an activation of the mesopontine and forebrain structures involved in the behavioural and metabolic integration of the autonomic control and arousal and psychophysical-exercise stress. 2000 Academic Press@p$hr

Marathons in altitude

PURPOSE

We examined the effect of altitude up to 5200 m on marathon (42,195 m) performances.

METHODS

Eight elite and four good runners participated in a marathon at 4300-m altitude (A1), and five elite runners participated both in A1 and in a marathon at 5200-m altitude (A2). The maximal aerobic power (VO2max) was determined indirectly in altitude during A1 and A2 expeditions from the scores of a 12-min running test. The fractions of VO2max utilized during both races were calculated from the linear relationship between running speed and VO2 described by Costill and Fox (1969).

RESULTS

VO2max significantly decreases with altitude (P<0.001). We found a linear relationship (R2 = 0.73, P<0.001) between the speed of each participant in the sea level marathon and the speed of A1. The mean difference between the sea level and the A1 speed was 35+/-9% (P<0.001). In A1, elite runners utilized 63+/-8% whereas good runners utilized 52+/-8% of VO2max (P<0.001). The five elite runners utilized 74+/-6%; 67+/-1% (P< 0.01), and 71+/-3% (P<0.01) of their VO2max at sea level, A1, and A2, respectively. In Al, the mean heart rate (HR) was higher in elite than in good runners (P<0.001), whereas the percentage of maximum theoretical HR was 83+/-3% and 81+/-5%, respectively (P>0.05).

CONCLUSIONS

Marathon performance in altitude is mainly affected by the lower VO2max. The better performance of elite marathoners in altitude compared with good runners was related to the higher % of VO2max maintained during every marathon. The differences between the expected and the observed performances at high altitude depend on the uneven running path and on a poorer economy of running that is related to the higher mechanical work of breathing. The fractional utilization of VO2max seems lowered by acute exposure to altitude and slightly increases with acclimatization.